Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes

The field of nanomedicine has been fruitful in creating novel drug delivery ideas to battle hematologic cancers. However, one persistent barrier to efficient nanoparticle treatment is phagocytic uptake or the clearance of nanoparticles by immune cells. To prevent this immune uptake, scientists have...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura A. Weinstein, Bingqing Wei
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/15/10/739
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849326977721303040
author Laura A. Weinstein
Bingqing Wei
author_facet Laura A. Weinstein
Bingqing Wei
author_sort Laura A. Weinstein
collection DOAJ
description The field of nanomedicine has been fruitful in creating novel drug delivery ideas to battle hematologic cancers. However, one persistent barrier to efficient nanoparticle treatment is phagocytic uptake or the clearance of nanoparticles by immune cells. To prevent this immune uptake, scientists have utilized biomimicry, the emulation of natural structures for engineered applications, to create particles that are able to remain unrecognized by immune cells. This method aims to improve the overall circulation time of nanoparticles by decreasing the amount of particles filtered out of the blood. It can even lead to homotypic cancer cell targeting, decreasing cancer cell vitality. This review summarizes recent in vivo and in vitro studies to prove that biomimetic cargo delivery is a unique and tenable way of increasing survival outcomes in patients with hematologic cancers.
format Article
id doaj-art-fd2f35fdbccd4da4865f4264c3265a46
institution Kabale University
issn 2079-4991
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Nanomaterials
spelling doaj-art-fd2f35fdbccd4da4865f4264c3265a462025-08-20T03:48:01ZengMDPI AGNanomaterials2079-49912025-05-01151073910.3390/nano15100739Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer OutcomesLaura A. Weinstein0Bingqing Wei1Department of Biomedical Engineering, University of Delaware, Newark 19716, DE, USADepartment of Mechanical Engineering, University of Delaware, Newark 19716, DE, USAThe field of nanomedicine has been fruitful in creating novel drug delivery ideas to battle hematologic cancers. However, one persistent barrier to efficient nanoparticle treatment is phagocytic uptake or the clearance of nanoparticles by immune cells. To prevent this immune uptake, scientists have utilized biomimicry, the emulation of natural structures for engineered applications, to create particles that are able to remain unrecognized by immune cells. This method aims to improve the overall circulation time of nanoparticles by decreasing the amount of particles filtered out of the blood. It can even lead to homotypic cancer cell targeting, decreasing cancer cell vitality. This review summarizes recent in vivo and in vitro studies to prove that biomimetic cargo delivery is a unique and tenable way of increasing survival outcomes in patients with hematologic cancers.https://www.mdpi.com/2079-4991/15/10/739nanomedicinebiomimicrydrug deliverycancerhomotypic targeting
spellingShingle Laura A. Weinstein
Bingqing Wei
Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes
Nanomaterials
nanomedicine
biomimicry
drug delivery
cancer
homotypic targeting
title Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes
title_full Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes
title_fullStr Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes
title_full_unstemmed Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes
title_short Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes
title_sort hiding in plain sight cell biomimicry for improving hematological cancer outcomes
topic nanomedicine
biomimicry
drug delivery
cancer
homotypic targeting
url https://www.mdpi.com/2079-4991/15/10/739
work_keys_str_mv AT lauraaweinstein hidinginplainsightcellbiomimicryforimprovinghematologicalcanceroutcomes
AT bingqingwei hidinginplainsightcellbiomimicryforimprovinghematologicalcanceroutcomes